![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » RECEPTOPHARM SIGNS LETTER OF INTENT TO BE AQUIRED BY NUTRA PHARMA CORPORATION
RECEPTOPHARM SIGNS LETTER OF INTENT TO BE AQUIRED BY NUTRA PHARMA CORPORATION
June 19, 2006
Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that ReceptoPharm has signed a letter of intent to be fully acquired by Nutra Pharma Corp.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct